The association between disease activity and duration in systemic sclerosis

Journal of Rheumatology

Volumn 37, Issue 11, 2010, Pages 2299-2306

  Walker, Jennifer G ^a   Steele, Russell J ^b,c   Schnitzer, Mireille ^c   Taillefer, Suzanne ^b   Baron, Murray ^b,c   Hudson, Marie ^b,c   Abu Hakima, M ^d   Docherty, P ^d   Jones, N ^d   Kaminska, E ^d   Khalidi, N ^d   LeClercq, S ^d   Ligier, S ^d   Markland, J ^d   Masetto, A ^d   Mittoo, S ^d   Mathieu, J P ^d   Pope, J ^d   Robinson, D ^d   Smith, D ^d   Sutton, E ^d   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d NONE

Author keywords

Disease activity; Disease duration; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY FUNCTION; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SCLERODERMA; SCLERODERMA DISEASE ACTIVITY INDEX; SCORING SYSTEM; SKIN FUNCTION; SYSTEMIC SCLEROSIS;

ADULT; AGED; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 78149270549     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.090919     Document Type: Article

References (29)

1. Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 2003;29:211-37.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
3. Walker JG, Pope J, Baron M, LeClercq S, Hudson M, Taillefer S, et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007;26:1401-9.
4. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
5. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: Demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine 2002;81:139-53.
6. Reveille JD, Solomon DH, The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl-70 and nucleolar antibodies. Arthritis Rheum 2003;49:399-412.
7. Arnett F, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an imunogenetic, serological and clinical analysis. Arthritis Rheum 1996;39:1151-60.
8. Medsger TA Jr. Assessment of damage and activity in systemic sclerosis. Curr Opin Rheumatol 2000;12:545-8.
9. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indices. Ann Rheum Dis 2001;60:592-8.
10. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary criteria. Ann Rheum Dis 2003;62:901-3.
11. Valentini G, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003;62:904-5.
12. Radloff L. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
13. Radloff L, Locke B. Community surveys of psychiatric disorders. In: Weissman NM, Myers JK, Ross CE, editors. The Community Mental Health Assessment Surveys and the CES-D scale. New Brunswick, NJ: Rutgers University Press; 1986.
14. Ward MM. Are patient self-report measures of arthritis activity confounded by mood? A longitudinal study of patients with rheumatoid arthritis. J Rheumatol 1994;21:1046-50.
15. Cohen J, Cohen P, West S, Aiken L. Applied multiple regression/ correlation analysis for the behavioural sciences. 3rd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2003.
16. Mittlböck M. R2 measures for Poisson regression models. Computer Methods Prog Biomed 2002;68:205-14.
17. Kass R, Raftery A. Bayes factors. J Am Statist Assoc 1995;90:773-95.
18. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B, Csaki B, editors. Second International Symposium on Information Theory. Budapest: Academiai Kiado; 1973:267-81.
19. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman and Hall; 1989.
20. R Developent Core Team. R: A language and environment for statistical computing. Vienna; 2008. [Internet. Accessed June 30, 2010.] Available from: http://www.R-project.org
21. Lunn D, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Statistics Computing 2000;10:325-37.
22. Van Buuren S, Oudshoorn C. MICE: Multivariate imputation by chained equations. R package version 1.16.; 2007. [Internet. Accessed June 30, 2010.] Available from: http://web.inter.nl.net/users/S.van.Buuren/mi/hmtl/mice.htm
23. Raghunathan T, Lepkowski J, van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol 2001;27:85-95.
24. Schafer J. Analysis of incomplete multivariate data. New York: Chapman & Hall/CRC; 1997.
25. Steen V, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
26. Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M. Hypocomplementemia in systemic sclerosis - clinical and serological correlations. J Rheumatol 2007;34:2218-23.
27. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005;32:51-7.
28. Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, et al. Health values of patients with systemic sclerosis. Arthritis Rheum 2007;57:86-93.
29. Lilienfeld AM. Practical limitations of epidemiologic methods. Environ Health Perspect 1983;52:3-8.